0 Ratings
ID

23842

Description

Study part: Exploratory Biomarker Research Week 38 / Early Withdrawal visit.A Phase 2 Multicenter, Double-blind, Placebo-controlled, Study to to Evaluate the Corticosteroid- sparing effects of Mepolizumab in Subjects with Hypereosinophilic Syndromes (HES) and Evaluate Efficacy and Safety of Mepolizumab in Controlling the Clinical Signs and Symptoms of subjects with HES Patient Level Data: Study Listed on ClinicalStudyDataRequest.com. Sponsor: GlaxoSmithKline. Study ID: 100185, Clinical Study ID:MHE100185.

Keywords

Versions (1)
  1. 7/15/17 7/15/17 -
Copyright Holder

GlaxoSmithKline

Uploaded on

July 15, 2017

DOI

To request one please log in.

License

Creative Commons BY-NC 3.0
Model comments :

You can comment on the data model here. Via the speech bubbles at the itemgroups and items you can add comments to those specificially.

Back to model comments
Itemgroup comments for :

Item comments for :

  • Newest
  • Oldest
  • Popular
  • Newest
    • Newest
    • Oldest
    • Popular

    No comments

    In order to download data models you must be logged in. Please log in or register for free.

    Exploratory Biomarker Research Week 38 Mepolizumab HES NCT00086658

    English

    Exploratory Biomarker Research Week 38

    1 forms  
    EXPLORATORY BIOMARKER RESEARCH
    Description

    EXPLORATORY BIOMARKER RESEARCH

    Alias
    UMLS CUI-1
    C0005516 (Biological Markers)
    Has the subject provided written consent for exploratory biomarker research?
    Description

    informed consent biomarker

    Data type

    boolean

    Alias
    UMLS CUI [1,1]
    C0021430 (Informed Consent)
    UMLS CUI [1,2]
    C0005516 (Biological Markers)
    Date of Assessment
    Description

    Date of Assessment

    Data type

    date

    Alias
    UMLS CUI [1]
    C2985720 (Assessment Date)
    Date of Assessment Skin Biopsy
    Description

    Date of Assessment Skin Biopsy

    Data type

    date

    Alias
    UMLS CUI [1,1]
    C2985720 (Assessment Date)
    UMLS CUI [1,2]
    C0150866 (Biopsy of skin procedure)
    SNOMED
    240977001
    Date of Assessment GI Biopsy
    Description

    Date of Assessment GI Biopsy

    Data type

    date

    Alias
    UMLS CUI [1,1]
    C2985720 (Assessment Date)
    UMLS CUI [1,2]
    C0005558 (Biopsy)
    SNOMED
    129314006
    LOINC
    LP68311-7
    UMLS CUI [1,3]
    C0017189 (Gastrointestinal tract structure)
    SNOMED
    51289009
    Back to the top of the page

    Similar models

    Exploratory Biomarker Research Week 38

    1 forms
    Name
    Type
    Description | Question | Decode (Coded Value)
    Data type
    Alias
    Item Group
    EXPLORATORY BIOMARKER RESEARCH
    C0005516 (UMLS CUI-1)
    informed consent biomarker
    Item
    Has the subject provided written consent for exploratory biomarker research?
    boolean
    C0021430 (UMLS CUI [1,1])
    C0005516 (UMLS CUI [1,2])
    Date of Assessment
    Item
    Date of Assessment
    date
    C2985720 (UMLS CUI [1])
    Date of Assessment Skin Biopsy
    Item
    Date of Assessment Skin Biopsy
    date
    C2985720 (UMLS CUI [1,1])
    C0150866 (UMLS CUI [1,2])
    Date of Assessment GI Biopsy
    Item
    Date of Assessment GI Biopsy
    date
    C2985720 (UMLS CUI [1,1])
    C0005558 (UMLS CUI [1,2])
    C0017189 (UMLS CUI [1,3])
    Back to the top of the page 

    Help

    Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

    Watch Tutorial